Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210035917 210030719 1.75 76.2 Disease modification (D) 2015-04-12 2015-05-11 Temozolomide + RT null null 210017673 TEMOZOLOMIDE + RT
210035918 210009133 1.78 72.4 Adjuvant (A) 2018-01-14 2018-01-29 IBRUTINIB N N 210017747 IBRUTINIB
210035919 210009137 1.57 85.3 Adjuvant (A) 2018-06-15 2018-06-16 Rituximab N N 210017755 RITUXIMAB
210035921 210009158 1.46 45.6 Palliative (P) 2012-12-21 2013-05-14 IBRUTINIB N N 210017842 IBRUTINIB
210035922 210019804 1.6 65 Adjuvant (A) 2014-11-13 2015-11-17 IBRUTINIB N N 210017908 IBRUTINIB
210035923 210019814 1.62 98.7 Not known (9) 2018-10-23 2018-10-25 Lomustine N N 210017973 LOMUSTINE
210035924 210009193 null 63 Palliative (P) null 2016-09-24 Lomustine 2 null 210017976 LOMUSTINE
210035925 210019825 1.81 0 Palliative (P) 2018-04-16 2018-04-16 Lomustine N N 210018027 LOMUSTINE
210035926 210009209 1.82 106 Palliative (P) 2017-03-09 2017-03-09 Rituximab N N 210018045 RITUXIMAB
210035927 210030762 1.64 56.8 Disease modification (D) null 2017-03-15 IBRUTINIB N N 210018065 IBRUTINIB
210035928 210009225 1.8 66 Disease modification (D) 2018-06-26 2018-06-26 Rituximab 2 N 210018080 RITUXIMAB
210035929 210009232 null 96.2 Adjuvant (A) 2015-06-04 2016-07-08 IBRUTINIB 02 N 210018105 IBRUTINIB
210035930 210019858 1.64 56 Disease modification (D) 2019-06-16 2019-06-16 Lomustine null null 210018165 LOMUSTINE
210035931 210026698 1.51 92 Palliative (P) 2018-01-11 2018-01-11 Rituximab 02 N 210018210 RITUXIMAB
210035932 210009256 null 71.7 null 2015-12-16 2015-12-22 Lomustine N N 210018213 LOMUSTINE
210035934 210009262 1.57 74.95 Disease modification (D) 2016-06-12 2017-02-23 Rituximab N N 210018227 RITUXIMAB
210035935 210026705 1.64 80 Disease modification (D) 2016-04-11 2016-09-09 Lomustine N N 210018243 LOMUSTINE
210035936 210009274 1.83 65.3 Palliative (P) 2015-12-20 2015-12-27 Lomustine Y N 210018264 LOMUSTINE
210035937 210019876 1.63 77.9 Palliative (P) 2014-12-27 2015-02-19 IBRUTINIB 2 N 210018266 IBRUTINIB
210035938 210009280 1.6 69.3 Disease modification (D) 2015-09-06 2015-09-06 IBRUTINIB N N 210018276 IBRUTINIB
210035939 210009282 1.91 109 null 2016-08-28 2016-08-30 Lomustine 02 N 210018278 LOMUSTINE
210035940 210009289 1.47 59.4 Curative (C) 2017-11-22 2018-08-11 Lomustine N N 210018288 LOMUSTINE
210035942 210009298 null 98.2 Palliative (P) 2018-05-02 2018-05-03 Lomustine N N 210018321 LOMUSTINE
210035943 210019893 1.6 70 Palliative (P) 2018-04-10 2018-03-13 Rituximab 02 N 210018334 RITUXIMAB
210035944 210030796 1.8 88.4 Palliative (P) 2013-10-23 2013-10-24 Lomustine N N 210018336 LOMUSTINE
210035945 210037405 1.76 0 Disease modification (D) 2012-05-18 2014-09-06 Rituximab 02 N 210018349 RITUXIMAB
210035946 210009314 1.82 63.5 null 2013-10-16 2013-10-16 Rituximab N N 210018353 RITUXIMAB
210035947 210009318 1.68 76 Palliative (P) 2016-10-10 2016-12-12 Lomustine 2 N 210018363 LOMUSTINE
210035948 210009326 null 0 Palliative (P) 2018-06-03 2018-06-05 Rituximab 1 N 210018380 RITUXIMAB
210035949 210009328 1.64 85.5 Disease modification (D) 2018-06-16 2018-12-27 IBRUTINIB 02 N 210018384 IBRUTINIB
210035950 210009338 1.29 51 Curative (C) null 2014-01-31 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB null null 210018415 FCR
210035951 210009340 null 74.9 Curative (C) 2014-06-17 2014-06-17 Bendamustine+Rituximab(Sub Courses) N null 210018417 BENDAMUSTINE + RITUXIMAB
210035952 210009343 1.5 20 Curative (C) 2013-11-08 2014-10-02 FCR Oral - Cycle 1 Y N 210018435 FCR
210035953 210009352 null null Curative (C) 2015-06-23 2015-07-02 BENDAMUSTINE + RITUXIMAB N N 210018451 BENDAMUSTINE + RITUXIMAB
210035954 210019928 1.77 78.7 Adjuvant (A) 2015-02-21 2015-04-21 FLAIR Trial Y N 210018466 FLAIR TRIAL
210035955 210019932 null 89.6 Curative (C) 2017-04-10 2017-12-08 VINCRISTINE Y null 210018484 VINCRISTINE
210035957 210009376 1.66 85.4 Palliative (P) 2017-12-25 2018-01-25 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 2 N 210018518 FCR
210035958 210019945 null null Curative (C) 2018-02-08 2018-06-01 FLAIR Trial Y N 210018537 FLAIR TRIAL
210035959 210034916 1.73 90 Curative (C) 2013-10-13 2013-12-18 Bendamustine+Rituximab (1st Course) null N 210018539 BENDAMUSTINE + RITUXIMAB
210035960 210009385 1.29 69.3 Palliative (P) 2017-08-01 2017-11-27 FLAIR Trial 1 N 210018557 FLAIR TRIAL
210035961 210009390 1.73 null Curative (C) 2013-09-23 2013-11-05 FCR Oral - Cycle 2 onwards 2 N 210018567 FCR
210035962 210026766 1.6 60.3 Curative (C) 2015-12-31 2016-11-18 FCR Oral - Cycle 2 onwards 02 N 210018577 FCR
210035963 210009395 1.7 46 Curative (C) 2017-01-02 2017-02-20 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB N N 210018579 FCR
210035964 210009400 1.86 69 Curative (C) 2016-09-10 2016-10-09 Bendamustine+Rituximab(Sub Courses) N N 210018581 BENDAMUSTINE + RITUXIMAB
210035965 210009402 1.77 57.8 Curative (C) 2015-05-17 2015-06-15 BENDAMUSTINE + RITUXIMAB N N 210018591 BENDAMUSTINE + RITUXIMAB
210035966 210019963 null null Curative (C) 2015-01-27 2015-02-08 FLAIR Trial N null 210018597 FLAIR TRIAL
210035967 210030818 1.7 null Curative (C) 2014-06-13 2014-06-13 FLAIR Trial Y N 210018608 FLAIR TRIAL
210035968 210009413 1.53 63 Palliative (P) 2017-05-19 2017-08-22 VINCRISTINE N N 210018641 VINCRISTINE
210035969 210009415 1.65 25.1 Curative (C) 2015-11-11 2016-10-15 BENDAMUSTINE + RITUXIMAB N N 210018654 BENDAMUSTINE + RITUXIMAB
210035970 210009423 1.76 18.1 Curative (C) null 2019-02-05 CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB 02 null 210018684 FCR